Condition
Non-Diabetic Patients
Total Trials
3
Recruiting
1
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
0.0%
-86.5% vs benchmark
Late-Stage Pipeline
67%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
0
Data Visualizations
Phase Distribution
2Total
P 4 (2)
Trial Status
Recruiting1
Terminated1
Active Not Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07143773Phase 4Recruiting
SGLT2i Safety and Efficacy on Kidney Allograft Function in Non-diabetic Kidney Transplant Recipients
NCT06933355Phase 4Active Not Recruiting
Acute Effects of SGLT2 Inhibitor on Kidney Allograft Oxygen Tension
NCT02024243TerminatedPrimary
Role of Tissue Oxygenation and the miR-210 Gene In Wound Healing
Showing all 3 trials